跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,286 条关于
“Pyruvate Kinase”
全部
4,286
临床试验
1,892
药物
460
机构
194
资讯
1,740
去年
Avanzanite Partners with Agios to Commercialize First-in-Class Pyruvate Kinase Activator Across Europe
5年前
Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
2年前
FDA Approves Pyrukynd as First Treatment for Pyruvate Kinase Deficiency
4年前
FDA Approves Pyrukynd (mitapivat) for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
去年
Agios' Mitapivat Receives Positive CHMP Opinion for Thalassemia Treatment in Europe
去年
European Commission Grants Orphan Drug Designation to Agios' Mitapivat for Sickle Cell Disease
去年
Agios Pharmaceuticals Advances Tebapivat for Sickle Cell Disease and Hemolytic Anemias
去年
Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease
去年
Novo Nordisk Advances Etavopivat for Sickle Cell Disease to Phase 3 After Positive Phase 2 Results
去年
Phase 3 RISE UP Trial of Mitapivat in Sickle Cell Disease Completes Enrollment
第 1 页,共 174 页
上一页
下一页